Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea · Delayed Price · Currency is KRW 990.00
-27.00 (-2.65%)
Mar 25, 2026, 7:48 AM KST
Enzychem Lifesciences Market Cap
Enzychem Lifesciences has a market cap or net worth of 76.86 billion as of April 29, 2026. Its market cap has decreased by -29.63% in one year.
Market Cap
76.86B
Enterprise Value
-9.90B
Revenue
67.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
990.00
Market Cap Chart
Since April 5, 2017, Enzychem Lifesciences's market cap has decreased from 217.47B to 76.86B, a decrease of -64.66%. That is a compound annual growth rate of -10.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 76.86B | -35.29% |
| Dec 30, 2025 | 118.78B | 4.40% |
| Dec 30, 2024 | 113.77B | -26.43% |
| Dec 28, 2023 | 154.65B | 10.86% |
| Dec 29, 2022 | 139.50B | -69.50% |
| Dec 30, 2021 | 457.39B | -47.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dongwha Pharm.Co.,Ltd | 167.42B |
| Kyongbo Pharmaceutical | 163.04B |
| Ilsung Is | 161.68B |
| Jeil Pharma Holdings | 137.09B |
| HANDOK | 135.63B |
| Ildong Holdings | 114.73B |
| CKD Bio | 109.28B |
| Kukje Pharma | 96.93B |